Certificates of Analysis

Read the analytical record.

Each document below was issued by an independent laboratory for one sample of one lot. Values are transcribed as printed; open the PDF for the full report. A published document is not a release statement for the lot.

LOT AVP-2608-127_0080-5 · AVP-2608-127-0080-5

KLOW

Dual-chamber cartridge · 80 mg

Open PDF ↗

Report: V260915-19 001
Name on original PDF: KLOW
Issuer: Vanguard Laboratory
Date reported: 2026-09-25 (printed 9/25/2026)
Method: HPLC-UV/VIS
Identity: Pass - Matches Ref. Standard
Chromatographic purity: >99.50%
Declared content: 50 mg/10 mg/10 mg/10 mg/1.5 mL
Measured content: GHK-Cu: 88.61 mg/1.5 mL · BPC-157: 19.73 mg/1.5 mL · TB-500: 15.60 mg/1.5 mL · KPV: 11.54 mg/1.5 mL

Document integrity · SHA-256

a88d52bfd749fd17d08990aa3cb5ec19284367d72d299b7c235714e392c6c310

The PDF uses “_” in the lot, equivalent to the label spelling. Measured quantities differ from declared content; see individual results in the original. Quantity interpretation is under review; identity, purity and quantity are separate results.

LOT AVP-2609-281-0040-3

MOTS-c

Dual-chamber cartridge · 40 mg

Open PDF ↗

Report: V260915-19 002
Name on original PDF: MOTS-C
Issuer: Vanguard Laboratory
Date reported: 2026-09-25 (printed 9/25/2026)
Method: HPLC-UV/VIS
Identity: Pass - Matches Ref. Standard
Chromatographic purity: 99.38%
Declared content: 40 mg/1.5 mL
Measured content: MOTS-C: 73.10 mg/1.5 mL

Document integrity · SHA-256

35087691c5cae8a678e8444d2f686ad24d5e19eeaa6dd74cfa635aee3f3204ba

Matching lot. The report declares 40 mg/1.5 mL and measures 73.10 mg/1.5 mL; these are distinct fields. Quantity interpretation is under review; identity, purity and quantity are separate results.

LOT AVP-2606-285-0050-6

SS-31

Dual-chamber cartridge · 50 mg

Open PDF ↗

Report: V260915-19 003
Name on original PDF: SS-31
Issuer: Vanguard Laboratory
Date reported: 2026-09-25 (printed 9/25/2026)
Method: HPLC-UV/VIS
Identity: Pass - Matches Ref. Standard
Chromatographic purity: 98.68%
Declared content: 50 mg/1.5 mL
Measured content: SS-31: 54.73 mg/1.5 mL

Document integrity · SHA-256

b58ec73e2a818121ef844aa33633afbdd02eab9e129b7d1c4a5425e30a0977e8

Report for the 50 mg presentation, code 285, and the lot above only. It does not cover the 25 mg variant.

LOT AVP-2608-245-0060-7

Retatrutide

Dual-chamber cartridge · 60 mg

Open PDF ↗

Report: V260915-19 004
Name on original PDF: GLP-3
Issuer: Vanguard Laboratory
Date reported: 2026-09-25 (printed 9/25/2026)
Method: HPLC-UV/VIS
Identity: Pass - Matches Ref. Standard
Chromatographic purity: >99.80%
Declared content: 60 mg/1.5mL
Measured content: GLP-3: 58.31 mg/1.5mL

Document integrity · SHA-256

bdde0a2d7770b024555ce306810c167556d3d0fea11e691b374dc570bd6642f2

Issued as GLP-3, mapped by Avitus to Retatrutide 60 mg, code 245. This report applies only to the stated lot and 60 mg presentation.

LOT AVP-2608-264-0060-8

Tirzepatide

Dual-chamber cartridge · 60 mg

Open PDF ↗

Report: V260915-19 005
Name on original PDF: GLP-2
Issuer: Vanguard Laboratory
Date reported: 2026-09-25 (printed 9/25/2026)
Method: HPLC-UV/VIS
Identity: Pass - Matches Ref. Standard
Chromatographic purity: >99.80%
Declared content: 60 mg/1.5mL
Measured content: GLP-2: 58.63 mg/1.5mL

Document integrity · SHA-256

4c56b9c9973d1ab546b487a3baee856fdee89bcff1e33c0193b705b91de886cf

Issued as GLP-2, mapped by Avitus to Tirzepatide 60 mg, code 264. This report applies only to the stated lot and 60 mg presentation.

LOT AVP-2605-131-0050-1

GHK-Cu

Dual-chamber cartridge · 50 mg

Open PDF ↗

Report: V260812-3 004
Name on original PDF: GHK-Cu
Issuer: Vanguard Laboratory
Date reported: 2026-09-08 (printed 9/8/2026)
Method: HPLC-UV/VIS
Identity: Pass · matches reference standard
Chromatographic purity: >99.80% + 0.18%
Declared content: 50 mg
Measured content: 46.59 mg

Document integrity · SHA-256

90b5790331dfc5ec7526d5162f8f03ebc2a84112a58ef0fbeb303db13d9625bb

LOT AVP-2607-335-0010-2

Selank

Dual-chamber cartridge · 10 mg

Open PDF ↗

Report: V260812-3 001
Name on original PDF: Selank
Issuer: Vanguard Laboratory
Date reported: 2026-09-08 (printed 9/8/2026)
Method: HPLC-UV/VIS
Identity: Pass · matches reference standard
Chromatographic purity: 99.37% + 0.18%
Declared content: 10 mg
Measured content: 11.85 mg

Document integrity · SHA-256

874c7dc2b335b5e3cff1e5fdf878ced6e6452afa2378570433e3d2b513bf455b

LOT AVP26093380010-4 · AVP-2609-338-0010-4

Semax

Dual-chamber cartridge · 10 mg

Open PDF ↗

Report: V260812-3 003
Name on original PDF: Semax
Issuer: Vanguard Laboratory
Date reported: 2026-09-08 (printed 9/8/2026)
Method: HPLC-UV/VIS
Identity: Pass · matches reference standard
Chromatographic purity: 97.77% + 0.18%
Declared content: 10 mg
Measured content: 10.70 mg

Document integrity · SHA-256

875b4464c22dd6209b3fed573aba0c846c204d7bc3333ff202ec2dca15310f62

Lot printed on the document without separators; shown as issued.

LOT AVP-2605-157-0500-2

NAD+

Dual-chamber cartridge · 500 mg / 2 mL (SKU 157, discontinued)

Open PDF ↗

Report: V260728-32 003
Name on original PDF: NAD+
Issuer: Vanguard Laboratory
Date reported: 2026-08-07 (printed 8/7/2026)
Method: HPLC-UV/VIS
Identity: Not reported on this document
Chromatographic purity: Total >99.80% + 0.18% · NAD+ 96.55% · nicotinamide 3.45%
Declared content: 500 mg
Measured content: 537 mg

Document integrity · SHA-256

2f61360da8e4325967b5adb316217203c6027965f20f45b09b76bee2f53863c8

This lot belongs to the discontinued 2 mL presentation (SKU 157). It does not describe the current 1.5 mL presentation (SKU 159).

Chromatographic purity is the area % of peaks identified as the intended compound; it is not absolute mass purity. The laboratory did not select the sample and does not attest its representativeness of the lot. These documents do not report sterility, endotoxins or stability.

For research use only. Not for human or veterinary use.